Shionogi & Co., Ltd. announced that at the Board of Directors Meeting held on March 25, 2014, the following Corporate Officer was appointed, effective April 1, 2014. Global Project Management Kazuhiro Hatanaka, Vice President, Pharmaceutical Development Division. Current Corporate Officers, Masaaki Goshima and Akio Tsubokura will retire on March 31, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,921 JPY | +0.63% | -2.92% | +1.81% |
05-14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
05-13 | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.81% | 12.5B | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- 4507 Stock
- News Shionogi & Co., Ltd.
- Shionogi & Co., Ltd. Announces Executive Changes